Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 5, 2010 | Gemin X Pharmaceuticals | $8.0M Series E | Caxton Advantage Life Sciences Fund, Sanderling Ventures | — |
| Apr 20, 2010 | Gemin X Pharmaceuticals | $16.0M Series D | Caxton Advantage Life Sciences Fund, Sanderling Ventures | — |